In his famous lecture, "There's Plenty of Room at the Bottom," Feynman predicted the future of nanoscale technology. He said, “The principles of physics, as far as I can see, do not speak against the possibility of maneuvering things atom by atom.” Today, his far-sighted vision has become a reality through the field of nanorobotics.
What is a Nanorobot? A nanorobot is an extremely tiny machine that is invisible to the naked eye. It can be as small as a nanometre—one billionth of a metre. They are so tiny that nearly 100,000 nanorobots could be lined up across the width of a single human hair!
In 1974, Japanese professor Norio Taniguchi first coined the term nanotechnology. Although the idea of nanorobotics initially sounded like science fiction, scientists gradually turned this invisible magic into reality. By the late 1990s, robotics researchers had begun using the term nanorobot officially, and from the early 2000s, modern research and commercial applications of nanorobotics started taking shape.
While delivering his lecture, Feynman had also told his colleague Albert Hibbs that one day these tiny machines would be able to enter the human body and cure diseases just like doctors.
Feynman was right. Recognising the enormous potential of nanorobotics in medicine, scientists began intensive research in the field. During the 1990s, Eric Drexler and Robert Freitas Jr. developed the mathematical and theoretical foundations for the use of nanorobots in medicine. In 1999, Freitas published the book Nanomedicine, which provided a clear roadmap for future research. As nanotechnology advanced, laboratories began developing miniature prototypes. Researchers started focusing on precise applications such as destroying cancer cells and targeted drug delivery.
Destroying cancer cells without harming healthy ones has long been one of medicine's greatest challenges. Conventional treatments like chemotherapy often damage healthy cells along with cancerous ones, causing severe side effects.
This is where nanorobots show their true potential.
Scientists designed nanorobots that could identify only cancer cells while leaving healthy cells untouched. Once a cancer cell is located, these robots can deliver drugs directly to it or even alter its DNA to destroy it.
The capabilities of nanorobots are not limited to cancer treatment. They also have enormous potential in treating complex diseases without surgery. Blood clots in the brain are one of the leading causes of stroke. Conventional surgery is often risky. Nanorobots could travel directly to the clot and dissolve it, potentially saving a patient's life. But these nanorobots have now become more than just automated; they have become living machines.
Recently, a team of biologists and computer scientists from Tufts University and the University of Vermont created a remarkable biological robot called the Xenobot using frog cells. This microscopic living robot can move rapidly on its own, push relatively heavy objects, work together with other Xenobots, and even repair itself when damaged.
A Xenobot is neither a conventional robot nor an ordinary living organism. It is a programmable living machine designed by humans to perform specific tasks. It is made entirely from frog stem cells, without any metal or mechanical components. Since it is composed of living cells, it naturally decomposes after completing its work, leaving behind no harmful waste.
Scientists collected stem cells from embryos of the African clawed frog (Xenopus laevis) and shaped them into specific forms without making any genetic modifications. The robot derives its name from the frog's scientific name.
The Xenobot is equipped with tiny hair-like structures called cilia. These cilia function like microscopic motors, helping the robot swim efficiently underwater. In addition, contractions of heart muscle cells enable the robot to propel itself by swimming or crawling.
One of the defining features of robotics is the ability to store information and use it to alter behaviour. Keeping this in mind, researchers at Tufts University engineered Xenobots with the ability to record one bit of information through a biological read/write system. To achieve this, they introduced a fluorescent reporter protein into the cells. When exposed to light of a specific wavelength, the protein changes colour. This allows the Xenobot to remember whether it has encountered a particular environment or chemical. The latest Xenobots contain an integrated fluorescent switch capable of recording exposure to blue light of around 390 nanometres. In the future, this molecular memory system could be adapted to detect and record radioactive contamination, chemical pollutants, medicines, or even signs of disease.
Scientists used an artificial intelligence (AI) algorithm to design Xenobots. First, a supercomputer tested thousands of virtual designs to determine which body shape would perform best. Only after identifying the most effective design did researchers physically build it in the laboratory using living cells. Because Xenobots are made of living tissue, they can heal themselves if cut or damaged, without any human intervention.
While scientists at Tufts University constructed the physical Xenobots, researchers at the University of Vermont simultaneously ran computer simulations of millions of different designs to observe how they behaved individually and in groups. Using the Deep Green supercomputer cluster at the University of Vermont's Advanced Computing Core, a team led by computer scientist and robotics expert Josh Bongard employed an evolutionary algorithm to simulate millions of random environmental conditions before selecting the best-performing designs.
The findings of this groundbreaking research were published in the journal Science Robotics. Josh Bongard said: "We want the Xenobots to do useful work. Right now we're giving them simple tasks, but ultimately our goal is to create a new kind of living machine that could, for example, remove microplastics from the oceans or clean pollutants from the soil."
Xenobots have fundamentally changed our understanding of what a robot can be. Scientists believe that in the future these living robots could play a major role in treating diseases such as cancer, Alzheimer's disease, and blocked arteries. Researchers are continuing to improve Xenobots so that they can survive longer, perform more complex tasks, and adapt more effectively to changing environments.
